To examine the activity of LDN-2014 in vivo, compound was dissolved in DMSO and delivered via IP injections into the well-established severe mouse model of SMA, “SMNΔ7” (Smn−/−; SMN2+/+; SMNΔ7+/+)21. Here, SMN2 is linked to proximal spinal muscular atrophy.